TITLE:
Efficacy and Safety In Poorly Controlled Type 2 Diabetics

CONDITION:
Diabetes Mellitus, Type 2

INTERVENTION:
rosiglitazone

SUMMARY:

      The purpose of this study is to gain safety and efficacy information in patients with type 2
      diabetes, who have not previously taken any oral antidiabetic medications, and who have an
      HbA1c value of greater than or equal to 10%, despite diet and exercise.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 70 Years
Criteria:

        Inclusion criteria:

          -  Type 2 diabetes

          -  Drug-naive.

          -  Laboratory test result for HbA1c of greater than or equal to 10%.

          -  Written informed consent.

        Exclusion criteria:

          -  Prior use of antidiabetic medications within 3 months of screening.

          -  Fluid retention (edema).

          -  Significant liver disease.

          -  Low red blood cells (anemia).

          -  Severe or unstable angina (chest pain).

          -  Congestive heart failure.

          -  Severe high blood pressure.

          -  Alcohol or drug abuse.

          -  Other inclusion or exclusion criteria to be determined by the physician and study
             sponsor.
      
